Back

Ischemic heart disease attributable to high body mass index in pakistan versus worldwide: an analysis of the global burden of disease study 2021

30 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Chronic coronary syndromes and comorbidities Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Buket Akinci

Biruni University Faculty of Health Sciences, Istanbul (Turkiye)

4 More presentations in this session

Presentation thumbnail
Lymphangiogenic factors and all-cause and cause-specific mortality and impact of chronic kidney disease on them in patients with suspected or known coronary artery disease: The EXCEED-J Study
Doctor H. Wada (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Age at diagnosis determines coronary artery risk in familial hypercholesterolemia: a population-based study
Doctor E. Nielsen Holck (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Impact of chronic kidney disease on left ventricular and left atrial structure and function in STEMI patients treated with primary PCI: a comprehensive echocardiographic analysis
Doctor J. Vratonjic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Renal filtration function and early complications after elective coronary artery bypass grafting
Professor O. Yepanchintseva (Kiev, UA)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic coronary syndromes and comorbidities

The Event

Event poster

ESC Congress 2025

30 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Global, regional and national burden of ischemic heart disease and its attributable risk factors from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021
thumbnail
Congress Presentation
Sex disparities in ischaemic heart disease mortality in South Asia: a global burden of disease 2021 analysis
thumbnail
Congress Presentation
Temporal trends and breakpoints in age standardized DAYS rates for ischemic heart disease global and country level analysis from 1990 to 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources